Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
about
Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strainsExpression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsMicro-NMR for rapid molecular analysis of human tumor samplesCirculating tumor cells: approaches to isolation and characterizationCirculating tumor cells in breast cancerCharacterization of DNA Methylation in Circulating Tumor CellsCurrent Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous SystemClinical application of circulating tumor cells in breast cancer: overview of the current interventional trialsCirculating glioma biomarkersAdvances in high-throughput single-cell microtechnologiesMinimal residual disease and circulating tumor cells in breast cancerFuture directions for the early detection of recurrent breast cancerCirculating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic CancerPotential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current EvidenceProbing circulating tumor cells in microfluidics.Detection of cancer before distant metastasisMultiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.Clinical relevance and current challenges of research on disseminating tumor cells in cancer patientsCirculating Tumor Cells in Early-Stage Breast Cancer.Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancerA novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.HER2-positive circulating tumor cells in breast cancerRole of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China.Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.Circulating tumor cells in non-metastatic triple-negative breast cancer.Analysis of circulating tumor cells in breast cancer.Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study.Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus.Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionCTC enumeration and characterization: moving toward personalized medicine.Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patientsCirculating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancerA multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancerCirculating tumor cells in newly diagnosed inflammatory breast cancer.Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progressionClinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticityPrognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.Synthesis and characterization of Her2-NLP peptide conjugates targeting circulating breast cancer cells: cellular uptake and localization by fluorescent microscopic imaging.Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials
P2860
Q21132553-2B3DC514-5B15-44EE-A6BE-7AE314FEEF48Q21284707-72CB9BBB-49E2-415B-AEF7-8B8ACA12921CQ24603587-5D737512-9852-4062-94E5-1F95D23882C2Q24631347-FEBAE613-8BE8-4A03-992A-B005D48C438DQ26774808-CDA26517-35CE-415A-A42A-EC6EF9A667F8Q26778427-35D00372-E6B2-4507-ABC5-9A0A2B601A82Q26796208-A40B6550-327D-4A02-B564-A968859550BAQ26827936-1BB1778B-F38D-4D53-B471-73B176C72BAFQ26830329-CBFC770F-5A20-4A12-80FD-74CD30A30688Q26996412-5D01D3D3-304E-44E0-BBBB-429A5D6EB9E7Q27010152-4EA4FC29-F8FE-4F74-9213-94A19F49B157Q27022040-2E3F2D30-6499-4EF2-BFAF-760454EE2095Q28073765-52E47268-8D9D-4F34-A2CE-E24145A30828Q28075850-4E0C5E07-316A-4D97-B25F-7CE9B650DAA9Q30440019-46703C42-26DC-4B65-9590-7F72F8DDF712Q30540711-AA485460-D159-4D8A-9778-047C077B8953Q31006508-0DFBE2DE-83B6-424E-BD67-FCA6888ACB16Q33551239-9582980A-F803-49A0-BC52-F03F5855D1FDQ33555492-417212E4-DFA9-4CC6-977A-0468F503ECB2Q33579111-7D5CC7F5-557A-4EEA-BB8B-C0920F60EFCEQ33739272-637991D6-E008-4FD9-9B2B-F45B7B2DDDE1Q33741201-DE32413B-8C82-49AA-BA74-0CCCF262DEDDQ33802925-275F7488-B078-4F60-9D6B-EDB5D7CB79FCQ33858981-46A1D648-F773-442B-BD69-39B2E47CE7B2Q33997699-F6DDBD84-FAD2-4C2D-9B3D-10405F55F9FBQ34111867-E15ECF87-6AA5-4B8B-B7CE-4F3681BD97FBQ34156275-3524F14D-218A-4FB0-84FE-B8895481970EQ34371187-748A3CDA-36F7-4985-BAF9-3575D55852CFQ34372150-BF53624C-38C9-43B7-93DE-477019D7A7B1Q34496964-1676B480-9D40-412A-934B-CBB8B7C6DC37Q34577724-AAD53985-6961-4E9F-AEA5-908E0896217BQ34994963-69350AD7-FFAB-4D3A-A72F-7BB1F0D74EAEQ35006907-88971C7C-C21A-4758-BE52-37FC0FC611ECQ35034712-04F47E8F-2E62-44B9-B116-1B8771A6904AQ35052773-13991E0B-0394-43C9-B3FD-E7CD70137463Q35102335-A36A2641-C7DD-4314-B660-43F9BA308F45Q35124176-D4A7DCA9-F200-42B3-94A4-4A5444700B5CQ35427994-785CB87B-9DE4-410D-B649-D80CFF0723A2Q35548992-AD375C1A-7166-447A-BC2B-A9F5336EE041Q35583307-5EF41C9B-C56F-4320-9085-CD8DDE9CF88E
P2860
Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Circulating tumor cell detecti ...... n a phase II randomized trial.
@en
Circulating tumor cell detecti ...... n a phase II randomized trial.
@nl
type
label
Circulating tumor cell detecti ...... n a phase II randomized trial.
@en
Circulating tumor cell detecti ...... n a phase II randomized trial.
@nl
prefLabel
Circulating tumor cell detecti ...... n a phase II randomized trial.
@en
Circulating tumor cell detecti ...... n a phase II randomized trial.
@nl
P2093
P1476
Circulating tumor cell detecti ...... n a phase II randomized trial.
@en
P2093
Claire Mathiot
Etienne Brain
François-Clément Bidard
Jean-Yves Pierga
Michel Marty
Patricia de Cremoux
Rémy Salmon
Suzette Delaloge
Sylvie Giachetti
P304
P356
10.1158/1078-0432.CCR-08-0030
P407
P577
2008-11-01T00:00:00Z